Elevated expression of caspase-3 inhibitors, survivin and xIAP correlates with low levels of apoptosis in active rheumatoid synovium

Arthritis Research and Therapy

Volumn 11, Issue 1, 2009, Pages

  Dharmapatni, Anak A S S K ^a   Smith, Malcolm D ^b   Findlay, David M ^a   Holding, Christopher A ^a   Evdokiou, Andreas ^a   Ahern, Michael J ^b   Weedon, Helen ^b   Chen, Paul ^c   Screaton, Gavin ^d   Xu, Xiao N ^c   Haynes, David R ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b REPATRIATION GENERAL HOSPITAL   (Australia)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^d HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 3 INHIBITOR; SURVIVIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR; X LINKED INHIBITOR OF APOPTOSIS; BIRC5 PROTEIN, HUMAN; ENZYME INHIBITOR; MICROTUBULE ASSOCIATED PROTEIN; XIAP PROTEIN, HUMAN;

AGED; APOPTOSIS; ARTICLE; CELL TYPE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NICK END LABELING; OSTEOARTHRITIS; PROTEIN EXPRESSION; PROTEIN FAMILY; REAL TIME POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SYNOVIUM; DRUG ANTAGONISM; GENE EXPRESSION; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; APOPTOSIS; ARTHRITIS, RHEUMATOID; CASPASE 3; ENZYME INHIBITORS; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SYNOVIAL MEMBRANE; TNF-RELATED APOPTOSIS-INDUCING LIGAND; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 60849126397     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2603     Document Type: Article

References (50)

1. Hsu HC Wu Y Mountz JD Tumor necrosis factor ligand-receptor superfamily and arthritis Curr Dir Autoimmun 2006, 9:37-54. 16394654
2. Vaishnaw AK McNally JD Elkon KB Apoptosis in the rheumatic diseases Arthritis Rheum 1997, 40:1917-1927 10.1002/art.1780401102 9365079
3. Fujisawa K Asahara H Okamoto K Aono H Hasunuma T Kobata T Iwakura Y Yonehara S Sumida T Nishioka K Therapeutic effect of the anti-Fas antibody on arthritis in HTLV-1 tax transgenic mice J Clin Invest 1996, 98:271-278. 507427 8755634 10.1172/JCI118789
4. Okamoto K Asahara H Kobayashi T Matsuno H Hasunuma T Kobata T Sumida T Nishioka K Induction of apoptosis in the rheumatoid synovium by Fas ligand gene transfer Gene Ther 1998, 5:331-338. 10.1038/sj.gt.3300597 9614552
5. Nesterov A Ivashchenko Y Kraft AS Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) triggers apoptosis in normal prostate epithelial cells Oncogene 2002, 21:1135-1140. 10.1038/sj.onc.1205151 11850832
6. Pettersen I Figenschau Y Olsen E Bakkelund W Smedsrod B Sveinbjornsson B Tumor necrosis factor-related apoptosis-inducing ligand induces apoptosis in human articular chondrocytes in vitro Biochem Biophys Res Commun 2002, 296:671-676. 10.1016/S0006-291X(02)00916-6 12176034
7. Di Pietro R Mariggio MA Guarnieri S Sancilio S Giardinelli A Di Silvestre S Consoli A Zauli G Pandolfi A Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) regulates endothelial nitric oxide synthase (eNOS) activity and its localization within the human vein endothelial cells (HUVEC) in culture J Cell Biochem 2006, 97:782-794. 16229016 10.1002/jcb.20686
8. Diehl GE Yue HH Hsieh K Kuang AA Ho M Morici LA Lenz LL Cado D Riley LW Winoto A TRAIL-R as a negative regulator of innate immune cell responses Immunity 2004, 21:877-889. 10.1016/j.immuni.2004.11.008 15589175
9. Kimberley FC Screaton GR Following a TRAIL: Update on a ligand and its five receptors Cell Res 2004, 14:359-372. 10.1038/sj.cr.7290236 15538968
10. Emery JG McDonnell P Burke MB Deen KC Lyn S Silverman C Dul E Appelbaum ER Eichman C DiPrinzio R Dodds RA James IE Rosenberg M Lee JC Young PR Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL J Biol Chem 1998, 273:14363-14367. 10.1074/jbc.273.23.14363 9603945
11. Griffith TS Chin WA Jackson GC Lynch DH Kubin MZ Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells J Immunol 1998, 161:2833-2840. 9743343
12. Deveraux QL Takahashi R Salvesen GS Reed JC X-linked IAP is a direct inhibitor of cell-death proteases Nature 1997, 388:300-304. 10.1038/ 40901 9230442
13. Evdokiou A Bouralexis S Atkins GJ Chai F Hay S Clayer M Findlay DM Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to Apo2L/TRAIL-induced apoptosis Int J Cancer 2002, 99:491-504. 10.1002/ijc.10376 11992538
14. Degli-Esposti MA Dougall WC Smolak PJ Waugh JY Smith CA Goodwin RG The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain Immunity 1997, 7:813-820. 10.1016/S1074-7613(00)80399-4 9430226
15. Zhang XD Franco A Myers K Gray C Nguyen T Hersey P Relation of TNF-related apoptosis-inducing ligand (TRAIL) receptor and FLICE-inhibitory protein expression to TRAIL-induced apoptosis of melanoma Cancer Res 1999, 59:2747-2753. 10364001
16. Koornstra JJ Kleibeuker JH van Geelen CM Rijcken FE Hollema H de Vries EG de Jong S Expression of TRAIL (TNF-related apoptosis-inducing ligand) and its receptors in normal colonic mucosa, adenomas, and carcinomas J Pathol 2003, 200:327-335. 10.1002/path.1364 12845629
17. Song K Chen Y Goke R Wilmen A Seidel C Goke A Hilliard B Chen Y Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression J Exp Med 2000, 191:1095-1104. 2193179 10748228 10.1084/jem.191.7.1095
18. Ichikawa K Liu W Fleck M Zhang H Zhao L Ohtsuka T Wang Z Liu D Mountz JD Ohtsuki M Koopman WJ Kimberly R Zhou T TRAIL-R2 (DR5) mediates apoptosis of synovial fibroblasts in rheumatoid arthritis J Immunol 2003, 171:1061-1069. 12847280
19. Miranda-Carus ME Balsa A Benito-Miguel M De Ayala CP Martin-Mola E Rheumatoid arthritis synovial fluid fibroblasts express TRAIL-R2 (DR5) that is functionally active Arthritis Rheum 2004, 50:2786-2793. 10.1002/ art.20501 15457446
20. Miyashita T Kawakami A Nakashima T Yamasaki S Tamai M Tanaka F Kamachi M Ida H Migita K Origuchi T Nakao K Eguchi K Osteoprotegerin (OPG) acts as an endogenous decoy receptor in tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis of fibroblast-like synovial cells Clin Exp Immunol 2004, 137:430-436. 1809120 15270863 10.1111/j.1365-2249.2004.02534.x
21. Morel J Audo R Hahne M Combe B Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces rheumatoid arthritis synovial fibroblast proliferation through mitogen-activated protein kinases and phosphatidylinositol 3-kinase/Akt J Biol Chem 2005, 280:15709-15718. 10.1074/jbc.M414469200 15684417
22. Liu Z Xu X Hsu HC Tousson A Yang PA Wu Q Liu C Yu S Zhang HG Mountz JD CII-DC-AdTRAIL cell gene therapy inhibits infiltration of CII-reactive T cells and CII-induced arthritis J Clin Invest 2003, 112:1332-1341. 228459 14597760
23. Nicholson DW Ali A Thornberry NA Vaillancourt JP Ding CK Gallant M Gareau Y Griffin PR Labelle M Lazebnik YA Munday NA Raju SM Smulson ME Yamin T Yu VL Miller DK Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis Nature 1995, 376:37-43. 10.1038/376037a0 7596430
24. Schirmer M Vallejo AN Weyand CM Goronzy JJ Resistance to apoptosis and elevated expression of Bcl-2 in clonally expanded CD4+CD28- T cells from rheumatoid arthritis patients J Immunol 1998, 161:1018-1025. 9670983
25. Bokarewa M Lindblad S Bokarew D Tarkowski A Balance between survivin, a key member of the apoptosis inhibitor family, and its specific antibodies determines erosivity in rheumatoid arthritis Arthritis Res Ther 2005, 7:R349-358. 1065333 15743483 10.1186/ar1498
26. Miyashita T Kawakami A Tamai M Izumi Y Mingguo H Tanaka F Abiru S Nakashima K Iwanaga N Aratake K Kamachi M Arima K Ida H Migita K Origuchi T Tagashira S Nishikaku F Eguchi K Akt is an endogenous inhibitor toward tumor necrosis factor-related apoptosis inducing ligand-mediated apoptosis in rheumatoid synovial cells Biochem Biophys Res Commun 2003, 312:397-404. 10.1016/j.bbrc.2003.10.141 14637151
27. Perlman H Nguyen N Liu H Eslick J Esser S Walsh K Moore TL Pope RM Rheumatoid arthritis synovial fluid macrophages express decreased tumor necrosis factor-related apoptosis-inducing ligand R2 and increased decoy receptor tumor necrosis factor-related apoptosis-inducing ligand R3 Arthritis Rheum 2003, 48:3096-3101. 10.1002/art.11302 14613271
28. Arnett FC Edworthy SM Bloch DA McShane DJ Fries JF Cooper NS LA H Kaplan SR Liang MH Luthra HS Medsger TA Mitchell DM Neustadt DH Pinals RS Schaller JG Sharp JT Wilder RL Hunder GG The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum 1988, 31:315-324. 10.1002/art.1780310302 3358796
29. Altman R Bloch DA Bole G Borenstain D Brant K Christy W Cooke TD Greenwald R Hochberg M Howell D Kaplan D Koopman W Longley S III Mankin H McShane DJ Medsger T Jr Meenan R Mikkelsen W Moskowitz R Murphy W Rothschild B Segal M Sokoloff L Wolfe F Development of criteria for the classification and reporting of osteoarthritis: Classification of osteoarthritis of the knee Arthritis Rheum 1986, 29:1039-1049. 10.1002/ art.1780290816 3741515
30. Dougados M Linden van der S Juhlin R Huitfeldt B Amor B Calin A Cats A Dijkmans B Olivieri I Pasero G et al The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy Arthritis Rheum 1991, 34:1218-1227. 10.1002/ art.1780341003 1930310
31. Ch'en PF Xu XG Liu XS Liu Y Song CJ Screaton GR Jin BQ Xu XN Characterisation of monoclonal antibodies to the TNF and TNF receptor families Cell Immunol 2005, 236:78-85. 10.1016/j.cellimm.2005.08.010 16157320
32. Haynes DR Barg E Crotti TN Holding C Weedon H Atkins GJ Zannetino A Ahern MJ Coleman M Roberts-Thomson PJ Kraan M Tak PP Smith MD Osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathies and osteoarthritis and normal controls Rheumatology (Oxford) 2003, 42:123-134. 10.1093/ rheumatology/keg047 12509625
33. Smith MD O'Donnell J Highton J Palmer DG Rozenbilds M Roberts-Thomson PJ Immunohistochemical analysis of synovial membranes from inflammatory and non-inflammatory arthritides: Scarcity of CD5 positive B cells and IL2 receptor bearing T cells Pathology 1992, 24:19-26. 10.3109/ 00313029209063615 1374550
34. Crotti TN Smith MD Weedon H Ahern MJ Findlay DM Kraan M Tak PP Haynes DR Receptor activator NF-kappaB ligand (RANKL) expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathy, osteoarthritis, and from normal patients: Semiquantitative and quantitative analysis Ann Rheum Dis 2002, 61:1047-1054. 1753975 12429533 10.1136/ard.61.12.1047
35. Tak PP Lubbe van der PA Cauli A Daha MR Smeets TJ Kluin PM Meinders AE Yanni G Panayi GS Breedveld FC Reduction of synovial inflammation after anti-CD4 monoclonal antibody treatment in early rheumatoid arthritis Arthritis Rheum 1995, 38:1457-1465. 10.1002/art.1780381012 7575695
36. Krepela E Prochazka J Fiala P Zatloukal P Selinger P Expression of apoptosome pathway-related transcripts in non-small cell lung cancer J Cancer Res Clin Oncol 2006, 132:57-68. 10.1007/s00432-005-0048-6 16231180
37. Schultz IJ Kiemeney LA Witjes JA Schalken JA Willems JL Swinkels DW de Kok JB Survivin mRNA expression is elevated in malignant urothelial cell carcinomas and predicts time to recurrence Anticancer Res 2003, 23:3327-3331. 12926071
38. Lopes RB Gangeswaran R McNeish IA Wang Y Lemoine NR Expression of the IAP protein family is dysregulated in pancreatic cancer cells and is important for resistance to chemotherapy Int J Cancer 2007, 120:2344-2352. 10.1002/ijc.22554 17311258
39. Franssen ME Zeeuwen PL Vierwinden G Kerkhof van de PC Schalkwijk J van Erp PE Phenotypical and functional differences in germinative subpopulations derived from normal and psoriatic epidermis J Invest Dermatol 2005, 124:373-383. 10.1111/j.0022-202X.2004.23612.x 15675957
40. Livak KJ Schmittgen TD Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method Methods 2001, 25:402-408. 10.1006/meth.2001.1262 11846609
41. Zhang L Fang B Mechanisms of resistance to TRAIL-induced apoptosis in cancer Cancer Gene Ther 2005, 12:228-237. 10.1038/sj.cgt.7700792 15550937
42. Sheridan JP Marsters SA Pitti RM Gurney A Skubatch M Baldwin D Ramakrishnan L Gray CL Baker K Wood WI Goddard AD Godowski P Ashkenazi A Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors Science 1997, 277:818-821. 10.1126/science.277.5327.818 9242611
43. Kim K Fisher MJ Xu SQ el-Deiry WS Molecular determinants of response to TRAIL in killing of normal and cancer cells Clin Cancer Res 2000, 6:335-346. 10690508
44. Marsters SA Sheridan JP Pitti RM Huang A Skubatch M Baldwin D Yuan J Gurney A Goddard AD Godowski P Ashkenazi A A novel receptor for Apo2L/ TRAIL contains a truncated death domain Curr Biol 1997, 7:1003-1006. 10.1016/S0960-9822(06)00422-2 9382840
45. Jungel A Baresova V Ospelt C Simmen BR Michel BA Gay RE Gay S Seemayer CA Neidhart M Trichostatin A sensitises rheumatoid arthritis synovial fibroblasts for TRAIL-induced apoptosis Ann Rheum Dis 2006, 65:910-912. 10.1136/ard.2005.044065 16284094
46. Zhang XD Franco AV Nguyen T Gray CP Hersey P Differential localization and regulation of death and decoy receptors for TNF-related apoptosis-inducing ligand (TRAIL) in human melanoma cells J Immunol 2000, 164:3961-3970. 10754286
47. Smith MD Kraan MC Slavotinek J Au V Weedon H Parker A Coleman M Roberts-Thomson PJ Ahern MJ Treatment-induced remission in rheumatoid arthritis patients is characterized by a reduction in macrophage content of synovial biopsies Rheumatology (Oxford) 2001, 40:367-374. 10.1093/ rheumatology/40.4.367 11312372
48. Dohi T Okada K Xia F Wilford CE Samuel T Welsh K Marusawa H Zou H Armstrong R Matsuzawa S Salvesen GS Reed JC Altieri DC An IAP-IAP complex inhibits apoptosis J Biol Chem 2004, 279:34087-34090. 10.1074/ jbc.C400236200 15218035
49. Wu G Chai J Suber TL Wu JW Du C Wang X Shi Y Structural basis of IAP recognition by Smac/DIABLO Nature 2000, 408:1008-1012. 10.1038/35050012 11140638
50. Catrina AI Ulfgren AK Lindblad S Grondal L Klareskog L Low levels of apoptosis and high FLIP expression in early rheumatoid arthritis synovium Ann Rheum Dis 2002, 61:934-936. 1753901 12228167 10.1136/ ard.61.10.934